Incidence, predictors, and survival impact of acute kidney injury in patients with melanoma treated with immune checkpoint inhibitors: a 10-year single-institution analysis

Incidence, predictors, and survival impact of acute kidney injury in patients with melanoma treated with immune checkpoint inhibitors: a 10-year single-institution analysis

Background: The incidence of renal immune-related adverse events (irAEs) is reported to be 3.8%, with varied definitions of acute kidney injury (AKI). This study reports a 10-year experience at MD Anderson Cancer Center of patients diagnosed with melanoma and treated with immune checkpoint inhibitor...

Full description

Bibliographic Details
Main Authors: Maen Abdelrahim, Omar Mamlouk, Heather Lin, Jamie Lin, Valda Page, Noha Abdel-Wahab, Joshua Swan, Umut Selamet, Cassian Yee, Adi Diab, Wadi Suki, Ala Abudayyeh
Format: Article
Language:English
Published: Taylor & Francis Group 2021-01-01
Series:OncoImmunology
Subjects:
acute kidney injury
immune checkpoint inhibitor
melanoma
survival
Online Access:http://dx.doi.org/10.1080/2162402X.2021.1927313

Similar Items

Similar Items